glioblastoma phenotype

No related entities found.

Mentioned in (84)

Papers in which this entity is mentioned.

• A guide to transcriptomic deconvolution in cancer. (2026)
• Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma. (2025)
• Meta-analysis reveals differences in somatic alterations by genetic ancestry across common cancers. (2025)
• Analysis of multi-condition single-cell data with latent embedding multivariate regression. (2025)
• Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
• Rapid brain tumor classification from sparse epigenomic data. (2025)
• Functional analysis of cancer-associated germline risk variants. (2025)
• Three-dimensional genome landscape of primary human cancers. (2025)
• Flexynesis: A deep learning toolkit for bulk multi-omics data integration for precision oncology and beyond. (2025)
• High-Parameter Spatial Multi-Omics through Histology-Anchored Integration (2025)
• Detection and analysis of complex structural variation in human genomes across populations and in brains of donors with psychiatric disorders. (2024)
• Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. (2024)
• Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology. (2024)
• The Application of Long-Read Sequencing to Cancer. (2024)
• MYC-Targeting Inhibitors Generated from a Stereodiversified Bicyclic Peptide Library. (2024)
• ENPP1 Immunobiology as a Therapeutic Target. (2023)
• Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
• Towards understandings of serine/arginine-rich splicing factors. (2023)
• Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. (2022)
• Cell-free DNA technologies for the analysis of brain cancer. (2022)
• Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. (2021)
• Evaluating the transcriptional fidelity of cancer models. (2021)
• Integrative reconstruction of cancer genome karyotypes using InfoGenomeR. (2021)
• Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases. (2021)
• Macrophage Polarization States in the Tumor Microenvironment. (2021)
• Immuno-genomic landscape of osteosarcoma. (2020)
• Pan-cancer analysis of whole genomes. (2020)
• Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs. (2020)
• Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
• Astrocyte Reactivity: Subtypes, States, and Functions in CNS Innate Immunity. (2020)
• Neoadjuvant checkpoint blockade for cancer immunotherapy. (2020)
• Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
• CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers. (2019)
• Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. (2019)
• Comparative RNA-seq analysis aids in diagnosis of a rare pediatric tumor. (2019)
• The mutational footprints of cancer therapies. (2019)
• VCF2CNA: A tool for efficiently detecting copy-number alterations in VCF genotype data and tumor purity. (2019)
• mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma. (2019)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
• PI3K Signaling in Neurons: A Central Node for the Control of Multiple Functions. (2018)
• SvABA: genome-wide detection of structural variants and indels by local assembly. (2018)
• Patterns and mechanisms of structural variations in human cancer. (2018)
• OncoKB: A Precision Oncology Knowledge Base. (2017)
• The evolution of tumour phylogenetics: principles and practice. (2017)
• Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm. (2017)
• Patient-derived xenografts undergo mouse-specific tumor evolution. (2017)
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
• A method to reduce ancestry related germline false positives in tumor only somatic variant calling. (2017)
• Integrated digital error suppression for improved detection of circulating tumor DNA. (2016)
• Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers. (2016)
• Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. (2016)
• Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. (2015)
• Design and bioinformatics analysis of genome-wide CLIP experiments. (2015)
• Clock-like mutational processes in human somatic cells. (2015)
• CONSERTING: integrating copy-number analysis with structural-variation detection. (2015)
• Genome-wide analysis of noncoding regulatory mutations in cancer. (2014)
• Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. (2014)
• The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. (2014)
• Inferring tumour purity and stromal and immune cell admixture from expression data. (2013)
• Cancer genome landscapes. (2013)
• Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. (2013)
• Fusion genes and their discovery using high throughput sequencing. (2013)
• Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. (2013)
• Thalidomide-a notorious sedative to a wonder anticancer drug. (2013)
• Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. (2013)
• The Growing Importance of CNVs: New Insights for Detection and Clinical Interpretation. (2013)
• Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. (2013)
• Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. (2013)
• The genomic landscape of hypodiploid acute lymphoblastic leukemia. (2013)
• Pan-cancer patterns of somatic copy number alteration. (2013)
• Absolute quantification of somatic DNA alterations in human cancer. (2012)
• Myeloid cells in tumor inflammation. (2012)
• Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. (2012)
• GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. (2011)
• Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. (2011)
• Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. (2011)
• Parent-specific copy number in paired tumor-normal studies using circular binary segmentation. (2011)
• Allele-specific copy number analysis of tumors. (2010)
• Integrative analysis of the melanoma transcriptome. (2010)
• Network of Cancer Genes: a web resource to analyze duplicability, orthology and network properties of cancer genes. (2010)
• Recurring mutations found by sequencing an acute myeloid leukemia genome. (2009)
• Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. (2009)
• Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. (2007)
• Interleukin-1 is an astroglial growth factor in the developing brain. (1988)

Merged raw entities (1)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.